EyePoint Pharmaceuticals Inc. buy Citigroup Inc.
Start price
07.01.25
/
50%
€8.89
Target price
07.01.26
€31.74
Performance (%)
63.26%
End price
08.01.26
€14.52
Summary
This prediction ended on 08.01.26 with a price of €14.52. With a performance of 63.26% the BUY prediction by Citigroup_Inc_ was a big success. Citigroup_Inc_ has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 0.650% | 0.650% | 91.299% |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% |
Comments by Citigroup_Inc_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $33.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.50
09.03.26
09.03.26
€30.36
09.03.27
09.03.27
-23.42%
31.03.26
31.03.26
